Header

UZH-Logo

Maintenance Infos

Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis


Bloemberg, Guido V; Keller, Peter M; Stuckia, David; Trauner, Andrej; Borrell, Sonia; Latshang, Tsogyal; Coscolla, Mireia; Rothe, Thomas; Hömke, Rico; Ritter, Claudia; Feldmann, Julia; Schulthess, Bettina; Gagneux, Sebastien; Böttger, Erik C (2015). Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis. New England Journal of Medicine, 373(20):1986-1988.

Abstract

Treatment of multidrug-resistant Mycobacterium tuberculosis is a challenge. This letter describes the emergence of resistance to new therapies, bedaquiline and delamanid.

Abstract

Treatment of multidrug-resistant Mycobacterium tuberculosis is a challenge. This letter describes the emergence of resistance to new therapies, bedaquiline and delamanid.

Statistics

Citations

52 citations in Web of Science®
42 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

35 downloads since deposited on 17 Dec 2015
11 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > Institute of Medical Microbiology
Dewey Decimal Classification:570 Life sciences; biology
610 Medicine & health
Language:English
Date:12 November 2015
Deposited On:17 Dec 2015 11:20
Last Modified:08 Dec 2017 16:03
Publisher:Massachusetts Medical Society
ISSN:0028-4793
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:https://doi.org/10.1056/NEJMc1505196
PubMed ID:26559594

Download

Download PDF  'Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis'.
Preview
Content: Published Version
Filetype: PDF
Size: 457kB
View at publisher